BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
See today's BioWorld Asia
Home
» Other news to note for Nov. 17, 2020
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for Nov. 17, 2020
Nov. 17, 2020
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Abpro, Aikido, Altimmune, Amcure, Aravive, Astrazeneca, Atyr, Biontech, Biovaxys Technology, Bristol Myers Squibb, CCT Research, Collplant, CSL, Curevac, Farmacore, Guangzhou Baiyunshan, Hinova, Hitgen, Immuron, Johnson & Johnson, Kiadis, Lonza, Lung, Mallinckrodt, Nanoviricides, Noxopharm, Origimed, PDS, Pfizer, Pluristyx, Prestige, Qiagen, Recce, Reven, Selva, Sumitomo Dainippon, Sumitovant, Taiho, Takeda, Teva, Tscan, Urovant Sciences, Vaxart, Wuxi Advanced, Wuxi Apptec, Xoma, Xortx.
BioWorld Asia
Briefs
Other news to note